| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |